Catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia

Mauricio Arruda, Luciana Armaganijan, Tamer Fahmy, Luigi Di Biase, Dimpi Patel, Andrea Natale

Research output: Contribution to journalReview articlepeer-review

14 Scopus citations


Arrhythmogenic right ventricular dysplasia (ARVD) is a progressive, genetically determined fibro-fatty infiltrative myocardial disease with an estimated prevalence in the general population to be 1:5,000 to 1:10,000. ARVD leads to electrical instability that may predispose to life-threatening ventricular arrhythmia, heart failure, and sudden death. We reviewed the pathological substrate for ventricular arrhythmias, ECG findings and treatment modalities in ARVD. Importantly, novel techniques such as electroanatomic and voltage mapping has greatly improved the identification of the scared substrate in the settings of ARVD and have improved safety and efficacy of VT ablation procedures associated with this entity.

Original languageEnglish (US)
Pages (from-to)129-133
Number of pages5
JournalJournal of Interventional Cardiac Electrophysiology
Issue number2
StatePublished - Aug 2009
Externally publishedYes


  • ARVD
  • Ablation in arrhythmogenic right ventricular dysplasia
  • Arrhythmogenic right ventricular dysplasia
  • Catheter ablation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)


Dive into the research topics of 'Catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia'. Together they form a unique fingerprint.

Cite this